ABSTRACT
Inhaled pharmaceutical aerosols cannot act unless they deposit in the respiratory
tract. However, the amount and location of such deposition is strongly affected by
several factors, including aerosol properties, breath pattern, and lung geometry.
Since some control over aerosol properties and breath pattern is possible when
designing an inhaled aerosol formulation, access to tools that permit parametric
exploration of lung deposition is useful in order to optimize these parameters
and guide preclinical development. It is for this reason that methods allowing
simulation of deposition in the lung have become increasingly common in the
respiratory drug delivery arena.